John Craighead | Vice President of Investor Relations and Corporate Communications |
Isaac Ciechanover | President and Chief Executive Officer |
Dietmar Berger | Global Head of Research and Development |
Utpal Koppikar | Chief Financial Officer |
Anupam Rama | JPMorgan |
John Newman | Canaccord |
Salim Syed | Mizuho |
Matt Phipps | William Blair |
Maryana Breitman | Goldman Sachs |
Marc Frahm | Cowen and Company |
Maury Raycroft | Jefferies |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Atara Biotherapeutics First Quarter 2019 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference call will be recorded. I will now turn the call over to Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics.